Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Disruption of Metabolic Pathways - Perspectives for the Treatment of Cancer

Author(s): Eliana P. Araujo, Jose B. Carvalheira and Licio A. Velloso

Volume 6, Issue 1, 2006

Page: [77 - 87] Pages: 11

DOI: 10.2174/156800906775471734

Price: $65

Abstract

Several growth-promoting signaling pathways have tight molecular connections with metabolicrelated signal transduction systems. By controlling these pathways, cancer cells gain autonomy over energyacquiring systems and, thus, expand their potential for proliferation. Here, we discuss the use of drug and antisense oligonucleotide approaches to inhibit metabolic pathways in cancer cells and their potential use in the therapeutics of cancer.

Keywords: protein kinase B, protein remodeling, Akt Activation, phosphotyrosine binding (PTB), CCI-779, Antisense oligonucleotides

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy